Confirmatory drug test definition

Confirmatory drug test means a second analytical procedure performed on an aliquot of the original specimen to identify and quantify the presence of a specific drug or drug metabolite.
Sample 1Sample 2Sample 3
Confirmatory drug test means a second analytical procedure performed on a urine specimen to identify and quantify the presence of a specific drug or drug metabolite.
Sample 1Sample 2Sample 3
Confirmatory drug test means a second procedure to identify the presence of a specific drug or metabolite which is independent of the initial test and which uses a different technique and chemical principle from that of the initial test in order to ensure reliability and accuracy. At this time, gas chromatography/mass spectrometry (GC/MS) is the only authorized confirmation method for cocaine, marijuana, opiates, amphetamines, and phencyclidine.
Sample 1Sample 2Sample 3

Examples of Confirmatory drug test in a sentence

  • Confirmatory drug test - A second analytical procedure performed on a different aliquot of the original specimen to identify and quantify the presence of a specific drug or drug metabolite.

  • A negative Confirmatory drug test result will be deemed as fit-for-work and the Screen test declared a false non-negative.

  • Confirmatory drug test sample sent to Laboratory for analysis & the individual is sent home by suitable transport (at own cost) on paid Sick Leave for the remainder of that day / shift only.

  • Confirmatory drug test means a second analytical procedure performed on a different aliquot of the original specimen to identify and quantify the presence of a specific drug or drug metabolite.

  • A person with a positive Confirmatory drug test result will be deemed as not fit-for-work at the time of the Screen test.


More Definitions of Confirmatory drug test

Confirmatory drug test means a drug test given in respect of an initial drug test to determine the presence and level of a testable drug in a body sample.
Sample 1Sample 2Sample 3
Confirmatory drug test means a second analytical procedure to identify the presence of a specific drug or metabolite which is independent of the initial test and which uses a different technique and chemical principle from that of the initial test in order to ensure reliability and accuracy.
Sample 1Sample 2Sample 3
Confirmatory drug test means a follow-up drug test administered on samples that test positive as a result of an initial drug test. Confirmatory drug tests will utilize a different analytical method than the method used in initial drug tests. All confirmatory drug tests will consist of a chromatographic technique such as gas chromatography-mass spectrometry or a comparably reliable analytical method.
Sample 1
Confirmatory drug test means an analytical test using a device, tool or equipment with a different chemical or physical principle that is more specific which will validate and confirm the result of the screening test ; it refers to the second or further analytical procedure to more accurately determine the presence of dangerous drugs in specimen.
Sample 1

Related to Confirmatory drug test

  • Phase I Clinical Trial means for the purpose of obtaining Regulatory Approval a study in humans the purpose of which is preliminary determination of safety of a Product in healthy individuals or patients that would satisfy the requirements of 21 C.F.R. 312.21(a), or the equivalent process in other countries or groups of countries of the Territory.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase III Clinical Trial means a human clinical trial of a product, the design of which is acknowledged by the FDA to be sufficient for such clinical trial to satisfy the requirements of 21 C.F.R. 312.21(c) (as amended or any replacement thereof), or a similar human clinical trial prescribed by the Regulatory Authority in a country other than the United States, the design of which is acknowledged by such Regulatory Authority to be sufficient for such clinical trial to satisfy the requirements of a pivotal efficacy and safety clinical trial.

  • New Drug Application or “NDA” means a New Drug Application filed with the FDA as described in 21 C.F.R. § 314, a Biological License Application (BLA) pursuant to 21 C.F.R. § 601.2, or any equivalent or any corresponding application for Regulatory Approval (not including pricing and reimbursement approval) in any country or regulatory jurisdiction other than the United States.

  • IND means (a) an Investigational New Drug Application as defined in the FD&C Act and applicable regulations promulgated thereunder by the FDA, or (b) the equivalent application to the equivalent agency in any other regulatory jurisdiction, the filing of which is necessary to initiate or conduct clinical testing of a pharmaceutical product in humans in such jurisdiction.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by the JDC and that otherwise fit the foregoing definition.